hat
Teknoloji a kle a se nan konbine teknoloji a may nan CANNAPRESSO espesifik nebilizè may (patante pwodwi nan egzamen FDA 510K estanda aparèy medikal), nebulizing nan 0.4-0.5 ml / min to pulverizasyon nan teknoloji ultrason nan 130KHz frekans Vibration, pwodwi 2.5 μm sant ayewosòl patikil dirèkteman nan mukoza a nan poumon yo dwe absòbe.
eng
The key technology is to combine the mesh technology of CANNAPRESSO specific mesh nebulizer (patented product of FDA 510K test standard medical device), nebulizing at 0.4-0.5 ml / min atomization rate through ultrasound tech at 130KHz frequency Vibration, producing 2.5 μm center aerosol particle directly to the lung mucosa to be absorbed.